Morning Briefing
Summaries of health policy coverage from major news organizations
Lipitor Going Generic, Pfizer Making Deals To Keep Consumers
The popular cholesterol-lowering drug Lipitor goes off-patent today. Manufacturer Pfizer planned ahead, making agreements with some insurers to keep covering the drug.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
